Literature DB >> 27683917

Active immunotherapy may delay disability in progressive MS.

Aiden Haghikia1, Ralf Gold1.   

Abstract

Keywords:  IMMUNOLOGY; MRI; MULTIPLE SCLEROSIS

Mesh：

Year:  2016        PMID： 27683917     DOI： 10.1136/jnnp-2016-314377

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  1 in total

1.  Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study.

Authors:  Svenja Kramer; Arash Haghikia; Claudia Bang; Kristian Scherf; Angelika Pfanne; Alexander Duscha; Johannes Kaisler; Barbara Gisevius; Ralf Gold; Thomas Thum; Aiden Haghikia
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.